NCT04620616View on ClinicalTrials.gov

Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With Use of RELX ENDS Products by ENDS Consumers

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

September 11, 2020

Primary Completion Date

January 4, 2021

Study Completion Date

January 14, 2021

Conditions
Electronic Cigarette Use
Interventions
OTHER

RELX ENDS Tobacco Flavor

Ad libitum use of the RELX ENDS tobacco flavor product during 8-hour and 5-minute use sessions

OTHER

RELX ENDS Menthol Flavor

Ad libitum use of the RELX ENDS tobacco flavor product during 8-hour and 5-minute use sessions

OTHER

Subject Usual Brand ENDS

Ad libitum use of the usual brand product during 8-hour and 5-minute use sessions

Trial Locations (2)

66212

Altasciences Clinical Kansas, Inc, Overland Park

90630

WCCT Global, Inc, Cypress

All Listed Sponsors
lead

Cheerain HK Limited

INDUSTRY

NCT04620616 - Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With Use of RELX ENDS Products by ENDS Consumers | Biotech Hunter | Biotech Hunter